Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs VistaGen Therapeutics, Inc. (VTGN)

CollPlant Biotechnologies Ltd. Sponsored ADR and VistaGen Therapeutics, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and VistaGen Therapeutics, Inc. are of similar size ($7.5M and $7.3M). VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against −86.8%. VistaGen Therapeutics, Inc. has the higher net margin (−2,703.7% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, VistaGen Therapeutics, Inc. leads on 10 and CollPlant Biotechnologies Ltd. Sponsored ADR on 6.

Valuation

Metric CLGN VTGN Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 2.92 9.18
P/B 1.97 0.30 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.23 0.65
EV/Sales 26.12 (6.44) 8.98
Earnings yield (235.64%) (976.47%) (34.89%)
Free cash flow yield (193.83%) (854.68%) (24.52%)

Profitability

Metric CLGN VTGN Biotechnology median
Gross margin (321.70%) 100.00% 65.16%
Operating margin (3,900.94%) (2,785.69%) 0.00%
Net margin (3,934.91%) (2,703.72%) 0.00%
Free cash flow margin (3,522.64%) (2,490.88%) 0.00%
Return on equity (161.98%) (166.46%) (50.12%)
Return on assets (101.59%) (129.22%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN VTGN Biotechnology median
Revenue growth (TTM) (86.76%) 287.15% 6.26%
EPS growth (last fiscal year) 35.17% (9.58%) 29.88%
Revenue growth, 5-year CAGR (17.32%) 3.10% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 3.07 4.89
Net debt to EBITDA 0.56 0.63 1.01

Dividend

Metric CLGN VTGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN VTGN Biotechnology median
Market cap 7.45m 7.33m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack